SCHEMBL25911541

SCHEMBL25911541

O=c1[nH]c(I)cc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.60
GAA P10253 3/20 0.60
LOXL2 Q9Y4K0 1/20 0.56
CDC25B P30305 10/20 0.51
APAF1 O14727 6/20 0.51
ALDH1A1 P00352 5/20 0.51
CASP3 P42574 5/20 0.51
SENP8 Q96LD8 5/20 0.51
SENP7 Q9BQF6 5/20 0.51
HPGD P15428 4/20 0.51
SENP6 Q9GZR1 4/20 0.51
SAE1 Q9UBE0 4/20 0.51
UBA2 Q9UBT2 4/20 0.51
THRB P10828 4/20 0.51
MAPT P10636 3/20 0.51
RECQL P46063 2/20 0.51
UBE2I P63279 2/20 0.51
GALK1 P51570 1/20 0.51
SMAD3 P84022 1/20 0.51
ATG4B Q9Y4P1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10576775 0.77 CA2 (0.61) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL29488099 0.75 KDM4E (1.00) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL1687342 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL29784203 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL1818129 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL150458 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL5311576 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL6448568 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL1719778 0.75 LOXL2 (0.61) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL824574 0.75 KDM4E (1.00) KDM4EGAALOXL2CDC25BAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023156386-A2 PHARMACEUTICAL COMPOUND Duke Street Bio Limited (GB) 2023-08-24 WO disclosed
WO-2023134647-A1 PIPERAZINO RING-CONTAINING DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 优领医药科技(香港)有限公司 2023-07-20 WO disclosed